Financhill
Buy
69

LX Quote, Financials, Valuation and Earnings

Last price:
$10.77
Seasonality move :
-1.26%
Day range:
$10.06 - $10.92
52-week range:
$1.56 - $11.46
Dividend yield:
1.28%
P/E ratio:
11.97x
P/S ratio:
0.92x
P/B ratio:
1.20x
Volume:
9.3M
Avg. volume:
4.5M
1-year change:
463.87%
Market cap:
$1.8B
Revenue:
$2B
EPS (TTM):
$0.90
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.7B $1.8B $1.5B $1.8B $2B
Revenue Growth (YoY) 9.92% 4.45% -16.67% 25.68% 7.24%
 
Cost of Revenues $1.2B $872.2M $1B $1.2B $1.3B
Gross Profit $526.4M $890.4M $451.8M $638M $700.5M
Gross Profit Margin 31.2% 50.52% 30.76% 34.56% 35.39%
 
R&D Expenses $68.7M $85.1M $86.8M $72.6M $80.6M
Selling, General & Admin $250.1M $329.8M $315.2M $299.8M $301.3M
Other Inc / (Exp) -$97.1M -$36.8M $111.6M -$70.9M -$128.7M
Operating Expenses $318.8M $414.9M $402M $372.4M $381.9M
Operating Income $207.7M $475.5M $49.8M $265.6M $318.6M
 
Net Interest Expenses $11.2M $9.8M $8.3M $7.1M $1.3M
EBT. Incl. Unusual Items $99.3M $428.9M $153.1M $187.6M $188.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $13.1M $67.4M $30.2M $36.9M $35.3M
Net Income to Company $86.2M $361.5M $123M $150.7M --
 
Minority Interest in Earnings -- -$29.9K -$919.6K -- --
Net Income to Common Excl Extra Items $86.2M $361.5M $122M $150.7M $153.4M
 
Basic EPS (Cont. Ops) $0.47 $1.96 $0.70 $0.92 $0.93
Diluted EPS (Cont. Ops) $0.45 $1.77 $0.66 $0.90 $0.90
Weighted Average Basic Share $182.4M $184.2M $174M $164.3M $165.7M
Weighted Average Diluted Share $205.6M $207.5M $196.4M $179.9M $169.6M
 
EBITDA $126.1M $461.2M $183.5M $215.2M $189.9M
EBIT $110.6M $438.7M $161.4M $194.7M $189.9M
 
Revenue (Reported) $1.7B $1.8B $1.5B $1.8B $2B
Operating Income (Reported) $207.7M $475.5M $49.8M $265.6M $318.6M
Operating Income (Adjusted) $110.6M $438.7M $161.4M $194.7M $189.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $457.5M $343.7M $428.8M $487.6M $508.5M
Revenue Growth (YoY) 2.36% -24.88% 24.77% 13.71% 4.3%
 
Cost of Revenues $228.2M $154.2M $282.1M $312.8M $331.4M
Gross Profit $229.3M $189.4M $146.7M $174.8M $177.1M
Gross Profit Margin 50.12% 55.12% 34.21% 35.85% 34.82%
 
R&D Expenses $14.3M $25.6M $19.1M $18.9M $21M
Selling, General & Admin $70.7M $69.7M $73.1M $74.7M $77.8M
Other Inc / (Exp) -$50.4M -$44.9M -$821.8K -$79.4M -$18.1M
Operating Expenses $85M $95.2M $92.2M $93.6M $98.8M
Operating Income $144.2M $94.2M $54.5M $81.2M $78.3M
 
Net Interest Expenses $2.7M $2M $1.2M $1.4M $355.8K
EBT. Incl. Unusual Items $91.1M $47.3M $52.5M $329.4K $59.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14.2M $7.4M $10.2M -$1.4M $9.4M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- $20.8K $15.9K -- --
Net Income to Common Excl Extra Items $76.9M $40M $42.4M $1.7M $50.4M
 
Basic EPS (Cont. Ops) $0.42 $0.22 $0.26 $0.01 $0.30
Diluted EPS (Cont. Ops) $0.38 $0.20 $0.24 $0.01 $0.29
Weighted Average Basic Share $183M $184.4M $172.8M $164.3M $166.6M
Weighted Average Diluted Share $205.5M $206.7M $195.1M $172.5M $175.8M
 
EBITDA $93.8M $49.3M $53.7M $1.8M $60.2M
EBIT $93.8M $49.3M $53.7M $1.8M $60.2M
 
Revenue (Reported) $457.5M $343.7M $428.8M $487.6M $508.5M
Operating Income (Reported) $144.2M $94.2M $54.5M $81.2M $78.3M
Operating Income (Adjusted) $93.8M $49.3M $53.7M $1.8M $60.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.7B $1.8B $1.5B $1.8B $2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.2B $871.5M $1B $1.2B $1.3B
Gross Profit $530.9M $890.2M $445.9M $636.2M $700.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $68.5M $85.1M $87M $72.6M $80.6M
Selling, General & Admin $250.3M $329.7M $314.8M $300.2M $301.2M
Other Inc / (Exp) -$98.8M -$37.3M $114.5M -$67.8M -$128.7M
Operating Expenses $318.8M $414.9M $401.7M $372.8M $381.8M
Operating Income $212.1M $475.3M $44.2M $263.4M $318.6M
 
Net Interest Expenses $11.2M $9.8M $8.3M $7.1M $1.3M
EBT. Incl. Unusual Items $102.2M $428.3M $150.4M $188.5M $188.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $13.6M $67.3M $29.6M $37M $35.3M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -$29.9K -$954.9K -- --
Net Income to Common Excl Extra Items $88.6M $360.9M $119.8M $151.5M $153.3M
 
Basic EPS (Cont. Ops) $0.48 $1.96 $0.70 $0.92 $0.92
Diluted EPS (Cont. Ops) $0.39 $1.77 $0.65 $0.88 $0.90
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $113.4M $438.1M $158.7M $176.5M $238.9M
EBIT $113.4M $438.1M $158.7M $176.5M $238.9M
 
Revenue (Reported) $1.7B $1.8B $1.5B $1.8B $2B
Operating Income (Reported) $212.1M $475.3M $44.2M $263.4M $318.6M
Operating Income (Adjusted) $113.4M $438.1M $158.7M $176.5M $238.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $1.8B $1.5B $1.8B $2B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $871.5M $1B $1.2B $1.3B --
Gross Profit $890.2M $445.9M $636.2M $700.4M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $85.1M $87M $72.6M $80.6M --
Selling, General & Admin $329.7M $314.8M $300.2M $301.2M --
Other Inc / (Exp) -$37.3M $114.5M -$67.8M -$128.7M --
Operating Expenses $414.9M $401.7M $372.8M $381.8M --
Operating Income $475.3M $44.2M $263.4M $318.6M --
 
Net Interest Expenses $9.8M $8.3M $7.1M $1.5M --
EBT. Incl. Unusual Items $428.3M $150.4M $188.5M $188.6M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $67.3M $29.6M $37M $35.3M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$29.9K -$954.9K -- -- --
Net Income to Common Excl Extra Items $360.9M $119.8M $151.5M $153.3M --
 
Basic EPS (Cont. Ops) $1.96 $0.70 $0.92 $0.92 --
Diluted EPS (Cont. Ops) $1.77 $0.65 $0.88 $0.90 --
Weighted Average Basic Share $736.6M $705.2M $656.6M $662.8M --
Weighted Average Diluted Share $829.7M $773.2M $724.4M $678.5M --
 
EBITDA $438.1M $158.7M $176.5M $238.9M --
EBIT $438.1M $158.7M $176.5M $238.9M --
 
Revenue (Reported) $1.8B $1.5B $1.8B $2B --
Operating Income (Reported) $475.3M $44.2M $263.4M $318.6M --
Operating Income (Adjusted) $438.1M $158.7M $176.5M $238.9M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $239.4M $418M $216.6M $370.3M $308.8M
Short Term Investments -- -- $39.1M $28.2M --
Accounts Receivable, Net $752.8M $600.3M $927.3M $556.4M $639.5M
Inventory $7.2M $7.5M $7.8M $4.7M $3.1M
Prepaid Expenses $227.1M $265.3M $377.6M $432.8M $322.6M
Other Current Assets -- -- -- -- $181M
Total Current Assets $2.5B $2.6B $2.6B $2.6B $2.5B
 
Property Plant And Equipment $19.2M $30.6M $41.2M $63M $84M
Long-Term Investments $79.9M $73.6M $50.5M $36M $38.9M
Goodwill -- -- -- -- --
Other Intangibles $153.1M $151.6M $135M $126.6M $118.2M
Other Long-Term Assets $95.9M $153.1M $176.4M $142M $82.4M
Total Assets $3.1B $3.3B $3.3B $3.3B $3B
 
Accounts Payable $109.3M $69.3M $59.2M $158.2M $10.2M
Accrued Expenses $94.5M $131.7M $124.3M $128.5M $550.6M
Current Portion Of Long-Term Debt $717.2M $486.6M $934.7M $562.7M $471.9M
Current Portion Of Capital Lease Obligations $7M $8.4M $7.4M $5.8M --
Other Current Liabilities $40.3M $233.8M $124.8M $191.5M --
Total Current Liabilities $1.8B $1.6B $1.8B $1.7B $1.3B
 
Long-Term Debt $420.3M $404.7M $215.2M $138.3M $244.1M
Capital Leases -- -- -- -- --
Total Liabilities $2.3B $2B $2B $1.9B $1.6B
 
Common Stock $35.8K $37.2K $34.5K $33.9K $33.7K
Other Common Equity Adj $99.9M $143.2M $145.2M $154.2M $157.4M
Common Equity $840.4M $1.3B $1.3B $1.4B $1.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.1M $6.3M -- -- --
Total Equity $846.5M $1.3B $1.3B $1.4B $1.5B
 
Total Liabilities and Equity $3.1B $3.3B $3.3B $3.3B $3B
Cash and Short Terms $239.4M $418M $255.7M $398.5M $308.8M
Total Debt $1.4B $1.2B $1.3B $771.8M $716.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $239.4M $418M $216.6M $370.3M $308.8M
Short Term Investments -- -- $39.1M $28.2M --
Accounts Receivable, Net $752.8M $600.3M $927.3M $556.4M $639.5M
Inventory $7.2M $7.5M $7.8M $4.7M $3.1M
Prepaid Expenses $227.1M $265.3M $377.6M $432.8M $322.6M
Other Current Assets -- -- -- -- $181M
Total Current Assets $2.5B $2.6B $2.6B $2.6B $2.5B
 
Property Plant And Equipment $19.2M $30.6M $41.2M $63M $84M
Long-Term Investments $79.9M $73.6M $50.5M $36M $38.9M
Goodwill -- -- -- -- --
Other Intangibles $153.1M $151.6M $135M $126.6M $118.2M
Other Long-Term Assets $95.9M $153.1M $176.4M $142M $82.4M
Total Assets $3.1B $3.3B $3.3B $3.3B $3B
 
Accounts Payable $109.3M $69.3M $59.2M $158.2M $10.2M
Accrued Expenses $94.5M $131.7M $124.3M $128.5M $550.6M
Current Portion Of Long-Term Debt $717.2M $486.6M $934.7M $562.7M $471.9M
Current Portion Of Capital Lease Obligations $7M $8.4M $7.4M $5.8M --
Other Current Liabilities $40.3M $233.8M $124.8M $191.5M --
Total Current Liabilities $1.8B $1.6B $1.8B $1.7B $1.3B
 
Long-Term Debt $420.3M $404.7M $215.2M $138.3M $244.1M
Capital Leases -- -- -- -- --
Total Liabilities $2.3B $2B $2B $1.9B $1.6B
 
Common Stock $35.8K $37.2K $34.5K $33.9K $33.7K
Other Common Equity Adj $99.9M $143.2M $145.2M $154.2M $157.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.1M $6.3M -- -- --
Total Equity $846.5M $1.3B $1.3B $1.4B $1.5B
 
Total Liabilities and Equity $3.1B $3.3B $3.3B $3.3B $3B
Cash and Short Terms $239.4M $418M $255.7M $398.5M $308.8M
Total Debt $1.4B $1.2B $1.3B $771.8M $716.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $332.2M $86.2M $361.5M $123M $150.7M
Depreciation & Amoritzation $12.7M $15.5M $22.5M $22.1M $20.5M
Stock-Based Compensation $25.7M $28.8M $29.1M $23.3M $16.7M
Change in Accounts Receivable -$471.8M -$71.1M $3M -$78.6M -$328.8M
Change in Inventories -$7M $8.7M -$107.2K -$838.6K $3M
Cash From Operations -$112.7M -$30.6M $413.1M $14.7M $394M
 
Capital Expenditures $7.2M $12.5M $18.8M $22.2M $32.4M
Cash Acquisitions -- -- -- $7.7M --
Cash From Investing -$113.4M -$309.6M $64.2M -$358.6M $330M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$19.2M
Special Dividend Paid
Long-Term Debt Issued $1.9B $3.3B $3.2B $3.2B $2.8B
Long-Term Debt Repaid -$1.5B -$3.1B -$3.5B -$2.9B -$3.3B
Repurchase of Common Stock -$49.2M -- -- -$48.7M --
Other Financing Activities -$3.5M $5.8M -- $1.8M --
Cash From Financing $442.8M $178.7M -$275.6M $165.5M -$544.6M
 
Beginning Cash (CF) $361.5M $577.5M $439.8M $613.2M $414.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $216.7M -$161.5M $201.7M -$178.4M $179.4M
Ending Cash (CF) $577M $411.5M $637.9M $436.2M $594.2M
 
Levered Free Cash Flow -$119.9M -$43.1M $394.3M -$7.4M $361.6M
Period Ending 2021-03-22 2022-03-22 2023-03-22 2024-03-22
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-03-22 2022-03-22 2023-03-22 2024-03-22
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2022-03-22 2023-03-22 2024-03-22 2025-03-22 2026-03-22
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock